GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for phosphoenolpyruvate carboxykinase (ATP) (B2VJU9)

Analyse AlphaFold monomer V2.0 prediction for phosphoenolpyruvate carboxykinase (ATP)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B2VJU9
Type
protein
Length
539 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xb6e7C4580fc3C8083C98E2C233D8361824758CA3
Molecule
Phosphoenolpyruvate carboxykinase (ATP)
UniProt
B2VJU9
Pockets
3 · best druggability 0.73

Structure

1 distinct chain · 31% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphoenolpyruvate carboxykinase (ATP)protein53931% helix, 24% strandB2VJU9

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14760.730.8266empty
2990.390.7621empty
3960.370.7519empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.